Medicure Company Insiders

Medicure Management Team Effectiveness

The company has return on total asset (ROA) of (0.0647) % which means that it has lost $0.0647 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1839) %, meaning that it generated substantial loss on money invested by shareholders. Medicure's management efficiency ratios could be used to measure how well Medicure manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.06 in 2026. Return On Capital Employed is likely to climb to -0.11 in 2026. At this time, Medicure's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 16.1 M in 2026, whereas Non Currrent Assets Other are likely to drop slightly above 83.8 K in 2026. Common Stock Shares Outstanding is likely to drop to about 10.8 M in 2026. Net Loss is likely to climb to about (621.6 K) in 2026The market capitalization of Medicure is C$11.9 Million. Medicure holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as Medicure in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Medicure, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Medicure Workforce Comparison

Medicure Profit Margins

The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.

Medicure Benchmark Summation

Medicure Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Medicure often depends on how effective the management is. Medicure management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medicure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medicure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Medicure's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medicure. Check Medicure's Beneish M Score to see the likelihood of Medicure's management manipulating its earnings.

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.